Suppression of recurrent transient ischemic attacks by a statin agent

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Recent studies of hydroxy-methylglutaryl coenzyme A reductase inhibitors have demonstrated that therapy with statins is associated with a significant decrease in the risk of stroke and TIA in patients with coronary artery disease. The underlying mechanism responsible for this effect is unclear. The author presents two patients who had cessation of TIAs upon institution of statin therapy. A variety of non-lipid-lowering mechanisms may account for this beneficial effect. This initial observation, if confirmed by further study, may suggest a role for statin agents in preventing recurrent TIAs.

Original languageEnglish (US)
Pages (from-to)531-532
Number of pages2
JournalNeurology
Volume56
Issue number4
StatePublished - Feb 27 2001

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Transient Ischemic Attack
Coenzyme A
Coronary Artery Disease
Oxidoreductases
Stroke
Observation
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Suppression of recurrent transient ischemic attacks by a statin agent. / Alberts, M. J.

In: Neurology, Vol. 56, No. 4, 27.02.2001, p. 531-532.

Research output: Contribution to journalArticle

@article{6d0a81e6f8e8462fa34ad1f246c05729,
title = "Suppression of recurrent transient ischemic attacks by a statin agent",
abstract = "Recent studies of hydroxy-methylglutaryl coenzyme A reductase inhibitors have demonstrated that therapy with statins is associated with a significant decrease in the risk of stroke and TIA in patients with coronary artery disease. The underlying mechanism responsible for this effect is unclear. The author presents two patients who had cessation of TIAs upon institution of statin therapy. A variety of non-lipid-lowering mechanisms may account for this beneficial effect. This initial observation, if confirmed by further study, may suggest a role for statin agents in preventing recurrent TIAs.",
author = "Alberts, {M. J.}",
year = "2001",
month = "2",
day = "27",
language = "English (US)",
volume = "56",
pages = "531--532",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Suppression of recurrent transient ischemic attacks by a statin agent

AU - Alberts, M. J.

PY - 2001/2/27

Y1 - 2001/2/27

N2 - Recent studies of hydroxy-methylglutaryl coenzyme A reductase inhibitors have demonstrated that therapy with statins is associated with a significant decrease in the risk of stroke and TIA in patients with coronary artery disease. The underlying mechanism responsible for this effect is unclear. The author presents two patients who had cessation of TIAs upon institution of statin therapy. A variety of non-lipid-lowering mechanisms may account for this beneficial effect. This initial observation, if confirmed by further study, may suggest a role for statin agents in preventing recurrent TIAs.

AB - Recent studies of hydroxy-methylglutaryl coenzyme A reductase inhibitors have demonstrated that therapy with statins is associated with a significant decrease in the risk of stroke and TIA in patients with coronary artery disease. The underlying mechanism responsible for this effect is unclear. The author presents two patients who had cessation of TIAs upon institution of statin therapy. A variety of non-lipid-lowering mechanisms may account for this beneficial effect. This initial observation, if confirmed by further study, may suggest a role for statin agents in preventing recurrent TIAs.

UR - http://www.scopus.com/inward/record.url?scp=0035957086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035957086&partnerID=8YFLogxK

M3 - Article

C2 - 11222801

AN - SCOPUS:0035957086

VL - 56

SP - 531

EP - 532

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -